Raiff Partners’s Bristol-Myers Squibb BMY Stock Holding History

Raiff Partners’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	–	Sell	-50,000	Closed	-$2.6M	–	31
2014 Q1	$2.6M	Buy	+50,000	New	+$2.66M	1.91%	24

Other funds holding BMY

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Raiff Partners's BMY Position: Q2 2014 in Review

Raiff Partners sold out of Bristol-Myers Squibb (BMY) in Q2 2014, closing a stake of 50,000 shares — an estimated $2.6M sold.

Raiff Partners first reported a position in BMY in Q1 2014 and held it in 1 quarter. The position peaked at $2.6M in Q1 2014. 1,301 funds tracked by Wall St. Rank hold BMY as of Q2 2014.

Raiff Partners reported no remaining Bristol-Myers Squibb position as of Q2 2014 after selling out during the quarter.
Raiff Partners sold 50,000 Bristol-Myers Squibb shares in Q2 2014, an estimated $2.6M.
Raiff Partners first reported a position in Bristol-Myers Squibb in Q1 2014 and held it in 1 quarter.
Raiff Partners's Bristol-Myers Squibb position peaked at $2.6M in Q1 2014.
1,301 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2014.

Based on Raiff Partners's 13F filing for Q2 2014, filed 13 Aug 2014.